A detailed history of Ing Groep Nv transactions in Royalty Pharma PLC stock. As of the latest transaction made, Ing Groep Nv holds 114,600 shares of RPRX stock, worth $3.83 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
114,600
Holding current value
$3.83 Million
% of portfolio
0.02%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 03, 2025

BUY
$24.28 - $28.39 $2.78 Million - $3.25 Million
114,600 New
114,600 $2.92 Million
Q1 2024

May 10, 2024

SELL
$27.46 - $31.33 $266,362 - $303,901
-9,700 Reduced 21.0%
36,500 $1.11 Million
Q4 2023

Feb 08, 2024

BUY
$26.21 - $29.22 $1.21 Million - $1.35 Million
46,200 New
46,200 $1.3 Million

Others Institutions Holding RPRX

About Royalty Pharma plc


  • Ticker RPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 437,139,008
  • Market Cap $14.6B
  • Description
  • Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...
More about RPRX
Track This Portfolio

Track Ing Groep Nv Portfolio

Follow Ing Groep Nv and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ing Groep Nv, based on Form 13F filings with the SEC.

News

Stay updated on Ing Groep Nv with notifications on news.